The Vanguard Group 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 09:54 am Sale | 2024-12-31 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 2,985,952 6.020% | -1,383,039 (-31.66%) | Filing |
| 2024-11-12 4:47 pm Unchanged | 2024-09-30 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,368,991 8.830% | 0 (Unchanged) | Filing |
| 2024-11-04 1:49 pm Sale | 2024-09-30 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,368,991 8.830% | -71,847 (-1.62%) | Filing |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,440,838 10.090% | 78,412 (+1.80%) | Filing |
| 2023-05-10 09:49 am Purchase | 2023-04-28 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,362,426 10.040% | 89,932 (+2.10%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,272,494 9.870% | 218,528 (+5.39%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 4,053,966 9.480% | 718,668 (+21.55%) | Filing |
| 2021-02-10 11:47 am Sale | 2020-12-31 | 13G | REGENXBIO Inc. RGNX | The Vanguard Group | 3,335,298 8.920% | -85,802 (-2.51%) | Filing |